Endocrine and Metabolic Emergencies

The understanding of endocrine emergencies in prehospital medicine evolved alongside the broader scientific discovery of hormones and metabolic regulation. Before insulin was isolated in 1921, patients presenting with diabetic ketoacidosis had virtually no chance of survival once the condition reached a critical stage. Early emergency medical services lacked both the pharmacological tools and the diagnostic capabilities to intervene meaningfully. The progressive integration of blood glucose monitoring, intravenous dextrose administration, and glucagon injection into the prehospital scope of practice transformed survival outcomes for patients experiencing hypoglycemia, hyperglycemia, and adrenal crises.

Despite these advances, endocrine and metabolic emergencies remain a leading cause of altered mental status calls in EMS systems nationwide. The central question for the AEMT remains: how do you rapidly identify which metabolic derangement is causing a patient's deterioration, and what interventions within your scope can you deploy to stabilize them before hospital arrival?

The endocrine system functions as the body's chemical messaging network, releasing hormones directly into the bloodstream to regulate metabolism, growth, electrolyte balance, and stress responses. When this regulatory system fails—whether through insufficient hormone production, excessive secretion, or end-organ unresponsiveness—the resulting metabolic derangements can be rapidly life-threatening. The AEMT must understand the foundational principles that underpin these emergencies to recognize clinical presentations, prioritize interventions, and anticipate patient deterioration during transport.

As illustrated above, the body's normal regulatory mechanism relies on a tightly coordinated feedback loop between the pancreatic beta cells (producing insulin) and alpha cells (producing glucagon). When a patient eats, rising blood glucose stimulates insulin release, which signals cells throughout the body to absorb glucose for energy and storage. Between meals, dropping glucose levels trigger glucagon release, prompting the liver to convert stored glycogen back into glucose. In Type 1 diabetes, autoimmune destruction of beta cells eliminates insulin production entirely, meaning exogenous insulin is required to prevent ketoacidosis. In Type 2 diabetes, peripheral insulin resistance and progressive beta-cell failure cause the system to decompensate more gradually, but the end result can be equally devastating in the form of HHS.

Hypoglycemia — The Fastest Killer

Hypoglycemia is generally defined as a blood glucose level below 60 mg/dL, though symptoms may appear at higher or lower thresholds depending on the patient's baseline. The brain consumes approximately 120 grams of glucose per day and cannot store meaningful reserves, making it exquisitely sensitive to drops in circulating blood sugar. The pathophysiologic cascade begins with sympathetic nervous system activation—producing diaphoresis, tachycardia, tremor, and anxiety—as the body attempts to mobilize glucose reserves through catecholamine release. If blood glucose continues to fall, neuroglycopenic symptoms emerge: confusion, slurred speech, seizures, and eventually coma. The most common cause encountered by the AEMT is insulin overshoot in a diabetic patient who took their medication without eating, exercised excessively, or received an incorrect dose.

Diabetic Ketoacidosis (DKA) — The Acid Spiral

In DKA, the absence of insulin prevents glucose from entering cells despite hyperglycemia. The body interprets this cellular starvation as a fasting state and activates lipolysis—breaking down fatty acids in the liver through beta-oxidation. This process generates acetoacetate, beta-hydroxybutyrate, and acetone, collectively known as ketone bodies. These ketones are acidic, and their accumulation overwhelms the body's bicarbonate buffering system, producing a metabolic acidosis with an elevated anion gap. The resulting pH drop triggers Kussmaul respirations—deep, rapid breathing—as the respiratory system attempts to compensate by blowing off CO₂. Simultaneously, hyperglycemia causes osmotic diuresis, leading to profound dehydration and electrolyte losses, particularly potassium. The classic triad of DKA includes hyperglycemia (typically 300–800 mg/dL), ketonemia, and metabolic acidosis.

Hyperosmolar Hyperglycemic State (HHS) — The Dehydration Crisis

In HHS, enough residual insulin exists to prevent ketosis, but it is insufficient to control blood glucose levels. The result is extreme hyperglycemia—often exceeding 600 mg/dL and sometimes reaching over 1,000 mg/dL—causing massive osmotic diuresis. Patients develop severe dehydration (sometimes losing 8–12 liters of fluid), hyperosmolarity of the blood, and progressive neurological decline ranging from lethargy to coma. HHS develops more insidiously than DKA, typically over days to weeks, and carries a higher mortality rate (10–20% versus 1–5% for DKA). The absence of Kussmaul respirations and fruity breath odor distinguishes it clinically from DKA in the field.

Adrenal Crisis — Cortisol Collapse

The adrenal glands produce cortisol, a glucocorticoid essential for stress response, vascular tone, and glucose metabolism. Patients with primary adrenal insufficiency (Addison's disease) or those on chronic corticosteroid therapy who abruptly discontinue their medication cannot mount an adequate cortisol response to physiological stress. An acute adrenal crisis presents with severe hypotension that is refractory to fluid resuscitation, hypoglycemia, hyperkalemia, hyponatremia, and altered mental status. These patients may carry medical alert identification or a steroid emergency card. The AEMT should recognize this pattern and prioritize aggressive fluid resuscitation and rapid transport.

Differentiating between endocrine emergencies in the prehospital setting relies on a systematic approach that integrates scene size-up findings, patient history, physical examination, and point-of-care glucometry. The AEMT should develop a mental framework for categorizing patients with altered mental status, recognizing that endocrine emergencies frequently mimic stroke, intoxication, seizure, and other neurological conditions.

The following scenario demonstrates the step-by-step assessment and management approach an AEMT would use when encountering a patient with suspected hypoglycemia. Pay careful attention to how each assessment finding informs the next clinical decision.

The AEMT occupies a critical position in the EMS chain, possessing interventions beyond the basic EMT scope—including IV access, D10W administration, and glucagon—but lacking the pharmacological breadth of a paramedic, who can administer insulin drips, vasopressors, and sodium bicarbonate. Understanding what you can and cannot do is as important as understanding the pathophysiology itself.

Understanding what happens after AEMT handoff places your interventions in proper clinical context and helps you anticipate which patients will deteriorate rapidly. Advanced life support (ALS) management of endocrine emergencies extends well beyond the AEMT scope, involving insulin drips, electrolyte replacement, arterial blood gas analysis, and ICU-level monitoring. Recognizing these connections also helps you provide more effective reports during interfacility transfers and when working alongside paramedics.